Seeing those numbers move in the wrong direction is understandably unsettling. Rising beta-2 microglobulin (B2M) and M protein levels are markers that doctors watch closely, as increases can signal that smoldering myeloma may be progressing.
Here's what those changes can mean:
- Rising B2M is associated with more active or Show Full Answer
Seeing those numbers move in the wrong direction is understandably unsettling. Rising beta-2 microglobulin (B2M) and M protein levels are markers that doctors watch closely, as increases can signal that smoldering myeloma may be progressing.
Here's what those changes can mean:
- Rising B2M is associated with more active or advancing disease
- Rising M protein over time is a known risk factor for progression to active myeloma
- Together, these trends are important data points your care team needs to evaluate promptly Since this is high-risk smoldering myeloma, it's really important to contact your oncologist soon to discuss these results. They may want to:
- Increase monitoring frequency to track the trend more closely
- Order additional tests such as bone marrow biopsy or imaging to check for bone lesions or organ involvement
- Discuss whether treatment should begin, as some high-risk cases benefit from early intervention
One month's increase doesn't automatically mean a crisis, but the trend matters — and your care team is the best resource to interpret what these specific changes mean for you.
September 18
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
